Literature DB >> 9916122

Interleukin-5 transgenic mice show enhanced resistance to primary infections with Nippostrongylus brasiliensis but not primary infections with Toxocara canis.

L A Dent1, C M Daly, G Mayrhofer, T Zimmerman, A Hallett, L P Bignold, J Creaney, J C Parsons.   

Abstract

In this study, interleukin-5 (IL-5) transgenic mice with lifelong eosinophilia were assessed for resistance to primary infections with two tissue-invading nematodes, Nippostrongylus brasiliensis and Toxocara canis. Relative to nontransgenic littermates, three lines of IL-5 transgenic mice with varying degrees of eosinophilia all displayed enhanced resistance to N. brasiliensis. Although the timing of final worm expulsion was similar in transgenic and nontransgenic hosts, intestinal worms in transgenic mice were fewer in number throughout infection, failed to increase in size over the course of the infection, and were much less fecund. In contrast, T. canis larvae were recovered in similar numbers from tissues of transgenic mice with "low" or "high" eosinophilia and from nontransgenic mice. These results and other data suggest that eosinophils can contribute to host resistance to some parasite species. Parasite transit time through the host may correlate with relative sensitivity to eosinophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916122      PMCID: PMC96418     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The role of interleukin-5 in protective immunity to Strongyloides venezuelensis infection in mice.

Authors:  M Korenaga; Y Hitoshi; N Yamaguchi; Y Sato; K Takatsu; I Tada
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

2.  Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni.

Authors:  A Sher; R L Coffman; S Hieny; P Scott; A W Cheever
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse.

Authors:  A Sher; R L Coffman; S Hieny; A W Cheever
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

4.  Infection of IL5 transgenic mice with Mesocestoides corti induces very high levels of IL5 but depressed production of eosinophils.

Authors:  M Strath; L Dent; C Sanderson
Journal:  Exp Hematol       Date:  1992-02       Impact factor: 3.084

5.  Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis.

Authors:  J C Parsons; R B Grieve
Journal:  J Parasitol       Date:  1990-02       Impact factor: 1.276

6.  Depletion of eosinophils by anti-IL-5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection.

Authors:  F J Herndon; S G Kayes
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

7.  Eosinophils and resistance to Trichinella spiralis.

Authors:  D I Grove; A A Mahmoud; K S Warren
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

8.  Eosinophilia in transgenic mice expressing interleukin 5.

Authors:  L A Dent; M Strath; A L Mellor; C J Sanderson
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

9.  A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum.

Authors:  A A Mahmoud; K S Warren; P A Peters
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

10.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.

Authors:  A Tominaga; S Takaki; N Koyama; S Katoh; R Matsumoto; M Migita; Y Hitoshi; Y Hosoya; S Yamauchi; Y Kanai
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  32 in total

1.  Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G.

Authors:  M H Shin; H Kita; H Y Park; J Y Seoh
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 2.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 3.  Highlights of human toxocariasis.

Authors:  J F Magnaval; L T Glickman; P Dorchies; B Morassin
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

Review 4.  Immunity to gastrointestinal nematode infections.

Authors:  D Sorobetea; M Svensson-Frej; R Grencis
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

5.  Trapping and immobilization of Nippostrongylus brasiliensis larvae at the site of inoculation in primary infections of interleukin-5 transgenic mice.

Authors:  C M Daly; G Mayrhofer; L A Dent
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice.

Authors:  Ann Marie Galioto; Jessica A Hess; Thomas J Nolan; Gerhard A Schad; James J Lee; David Abraham
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Assessment of the diagnostic value of specific anti-Toxocara IgA in Slovakian patients suspected to have toxocarosis.

Authors:  Vojtech Boldiš; František Ondriska; Simona Lipková
Journal:  Folia Microbiol (Praha)       Date:  2017-12-06       Impact factor: 2.099

8.  Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen.

Authors:  R Shimogawara; N Hata; A Schuster; H Lesshafft; S Guedes de Oliveira; R Ignatius; N Akao; N Ohta; H Feldmeier
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

Review 9.  Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects.

Authors:  Dickson Despommier
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes.

Authors:  Dominic Rees-Roberts; Lisa M Mullen; Kleoniki Gounaris; Murray E Selkirk
Journal:  Int J Parasitol       Date:  2009-10-27       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.